Active Metro Infusion Center Trials

  • A multi-center, randomized, double-blind, placebo­controlled, parallel group, phase Ill study to evaluate the efficacy and safety of LNP023 in primary lgA nephropathy patients
  • A Phase 3, Double-blind, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of 2000 mg/kg ofTrappsol'”‘Cyclo”‘ (Hydroxypropyl-P-cyclodextrin) and Standard of Care Compared to Placebo and Standard of Care in Patients with Niemann-Pick Disease Type CI
  • Treatment Plan for ALS-Revexma™ #2201 Study